200 related articles for article (PubMed ID: 32578908)
1. Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment.
Jaureguiberry-Bravo M; Kelschenbach J; Murphy A; Carvallo L; Hadas E; Tesfa L; Scott TM; Rivera-Mindt M; Cunningham CO; Arnsten JH; Volsky DJ; Berman JW
J Leukoc Biol; 2021 Mar; 109(3):675-681. PubMed ID: 32578908
[TBL] [Abstract][Full Text] [Related]
2. Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14
Jaureguiberry-Bravo M; Lopez L; Berman JW
J Leukoc Biol; 2018 Dec; 104(6):1049-1059. PubMed ID: 29791013
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI.
Murphy AJ; Kelschenbach J; He H; Chao W; Kim BH; Volsky DJ; Berman JW
Front Immunol; 2022; 13():1004985. PubMed ID: 36275760
[TBL] [Abstract][Full Text] [Related]
4. Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.
Jaureguiberry-Bravo M; Wilson R; Carvallo L; Berman JW
Curr HIV Res; 2016; 14(5):417-430. PubMed ID: 27009099
[TBL] [Abstract][Full Text] [Related]
5. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes.
Carvallo L; Lopez L; Che FY; Lim J; Eugenin EA; Williams DW; Nieves E; Calderon TM; Madrid-Aliste C; Fiser A; Weiss L; Angeletti RH; Berman JW
J Immunol; 2015 Apr; 194(7):3246-58. PubMed ID: 25716997
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Opioids on HIV Neuropathogenesis.
Murphy A; Barbaro J; Martínez-Aguado P; Chilunda V; Jaureguiberry-Bravo M; Berman JW
Front Immunol; 2019; 10():2445. PubMed ID: 31681322
[TBL] [Abstract][Full Text] [Related]
8. CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice.
Kim BH; Hadas E; Kelschenbach J; Chao W; Gu CJ; Potash MJ; Volsky DJ
Sci Rep; 2023 Apr; 13(1):6577. PubMed ID: 37085605
[TBL] [Abstract][Full Text] [Related]
9. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
Sacktor N
J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
[TBL] [Abstract][Full Text] [Related]
10. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
[TBL] [Abstract][Full Text] [Related]
11. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
Gu CJ; Borjabad A; Hadas E; Kelschenbach J; Kim BH; Chao W; Arancio O; Suh J; Polsky B; McMillan J; Edagwa B; Gendelman HE; Potash MJ; Volsky DJ
PLoS Pathog; 2018 Jun; 14(6):e1007061. PubMed ID: 29879225
[TBL] [Abstract][Full Text] [Related]
12. Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice.
Kim BH; Kelschenbach J; Borjabad A; Hadas E; He H; Potash MJ; Nedelcovych MT; Rais R; Haughey NJ; McArthur JC; Slusher BS; Volsky DJ
AIDS; 2019 May; 33(6):973-984. PubMed ID: 30946151
[TBL] [Abstract][Full Text] [Related]
13. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
Hong S; Banks WA
Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
[TBL] [Abstract][Full Text] [Related]
14. Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
Nedelcovych MT; Kim BH; Zhu X; Lovell LE; Manning AA; Kelschenbach J; Hadas E; Chao W; Prchalová E; Dash RP; Wu Y; Alt J; Thomas AG; Rais R; Kamiya A; Volsky DJ; Slusher BS
J Neuroimmune Pharmacol; 2019 Sep; 14(3):391-400. PubMed ID: 31209775
[TBL] [Abstract][Full Text] [Related]
15. Efficient Expression of HIV in Immunocompetent Mouse Brain Reveals a Novel Nonneurotoxic Viral Function in Hippocampal Synaptodendritic Injury and Memory Impairment.
Kelschenbach J; He H; Kim BH; Borjabad A; Gu CJ; Chao W; Do M; Sharer LR; Zhang H; Arancio O; Potash MJ; Volsky DJ
mBio; 2019 Jul; 10(4):. PubMed ID: 31266862
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
17. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).
Ndhlovu LC; Umaki T; Chew GM; Chow DC; Agsalda M; Kallianpur KJ; Paul R; Zhang G; Ho E; Hanks N; Nakamoto B; Shiramizu BT; Shikuma CM
J Neurovirol; 2014 Dec; 20(6):571-82. PubMed ID: 25227930
[TBL] [Abstract][Full Text] [Related]
18. Factors related to HIV-associated neurocognitive impairment differ with age.
Fogel GB; Lamers SL; Levine AJ; Valdes-Sueiras M; McGrath MS; Shapshak P; Singer EJ
J Neurovirol; 2015 Feb; 21(1):56-65. PubMed ID: 25404233
[TBL] [Abstract][Full Text] [Related]
19. EcoHIV Infection of Primary Murine Brain Cell Cultures to Model HIV Replication and Neuropathogenesis.
Kim BH; Chao W; Hadas E; Borjabad A; Potash MJ; Volsky DJ
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793575
[TBL] [Abstract][Full Text] [Related]
20. When do models of NeuroAIDS faithfully imitate "the real thing"?
Gelman BB; Endsley J; Kolson D
J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
